Figure 6.
PBMCs from three lung cancer patients (Pt01, Pt02 and Pt03) and seven breast cancer patients (Pt04 to Pt10) were stimulated with HLA-G26–40 peptide and re-stimulated with the peptide on day 7. The supernatant of each culture was collected on day 14 and analyzed by ELISA for IFNγ production. Bars and error bars indicate the mean and SD, respectively. Experiments were performed in duplicate. (*p < 0.05, Student's t test). Bars and error bars indicate the mean and SD, respectively. Experiments were performed in duplicate.